Global Vaccine Adjuvants Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Vaccine Adjuvants Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Aluminum Adjuvant
  • 1.2.3 Emulsions Adjuvant
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Human Vaccine
  • 1.3.3 Veterinary Vaccine
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
• 2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Vaccine Adjuvants Sales by Region
  • 2.4.1 Global Vaccine Adjuvants Sales by Region (2017-2022)
  • 2.4.2 Global Sales Vaccine Adjuvants by Region (2023-2028)
• 2.5 Global Vaccine Adjuvants Revenue by Region
  • 2.5.1 Global Vaccine Adjuvants Revenue by Region (2017-2022)
  • 2.5.2 Global Vaccine Adjuvants Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Vaccine Adjuvants Sales by Manufacturers
  • 3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Adjuvants in 2021
• 3.2 Global Vaccine Adjuvants Revenue by Manufacturers
  • 3.2.1 Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2021
• 3.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Vaccine Adjuvants Sales by Type
  • 4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2017-2022)
  • 4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• 4.2 Global Vaccine Adjuvants Revenue by Type
  • 4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• 4.3 Global Vaccine Adjuvants Price by Type
  • 4.3.1 Global Vaccine Adjuvants Price by Type (2017-2022)
  • 4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Vaccine Adjuvants Sales by Application
  • 5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2017-2022)
  • 5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• 5.2 Global Vaccine Adjuvants Revenue by Application
  • 5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• 5.3 Global Vaccine Adjuvants Price by Application
  • 5.3.1 Global Vaccine Adjuvants Price by Application (2017-2022)
  • 5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Vaccine Adjuvants Market Size by Type
  • 6.1.1 North America Vaccine Adjuvants Sales by Type (2017-2028)
  • 6.1.2 North America Vaccine Adjuvants Revenue by Type (2017-2028)
• 6.2 North America Vaccine Adjuvants Market Size by Application
  • 6.2.1 North America Vaccine Adjuvants Sales by Application (2017-2028)
  • 6.2.2 North America Vaccine Adjuvants Revenue by Application (2017-2028)
• 6.3 North America Vaccine Adjuvants Market Size by Country
  • 6.3.1 North America Vaccine Adjuvants Sales by Country (2017-2028)
  • 6.3.2 North America Vaccine Adjuvants Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Vaccine Adjuvants Market Size by Type
  • 7.1.1 Europe Vaccine Adjuvants Sales by Type (2017-2028)
  • 7.1.2 Europe Vaccine Adjuvants Revenue by Type (2017-2028)
• 7.2 Europe Vaccine Adjuvants Market Size by Application
  • 7.2.1 Europe Vaccine Adjuvants Sales by Application (2017-2028)
  • 7.2.2 Europe Vaccine Adjuvants Revenue by Application (2017-2028)
• 7.3 Europe Vaccine Adjuvants Market Size by Country
  • 7.3.1 Europe Vaccine Adjuvants Sales by Country (2017-2028)
  • 7.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Vaccine Adjuvants Market Size by Type
  • 8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2028)
• 8.2 Asia Pacific Vaccine Adjuvants Market Size by Application
  • 8.2.1 Asia Pacific Vaccine Adjuvants Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2028)
• 8.3 Asia Pacific Vaccine Adjuvants Market Size by Region
  • 8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Vaccine Adjuvants Market Size by Type
  • 9.1.1 Latin America Vaccine Adjuvants Sales by Type (2017-2028)
  • 9.1.2 Latin America Vaccine Adjuvants Revenue by Type (2017-2028)
• 9.2 Latin America Vaccine Adjuvants Market Size by Application
  • 9.2.1 Latin America Vaccine Adjuvants Sales by Application (2017-2028)
  • 9.2.2 Latin America Vaccine Adjuvants Revenue by Application (2017-2028)
• 9.3 Latin America Vaccine Adjuvants Market Size by Country
  • 9.3.1 Latin America Vaccine Adjuvants Sales by Country (2017-2028)
  • 9.3.2 Latin America Vaccine Adjuvants Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
  • 10.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
  • 10.2.1 Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
  • 10.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Corporation Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GSK Recent Developments
• 11.2 CSL Limited
  • 11.2.1 CSL Limited Corporation Information
  • 11.2.2 CSL Limited Overview
  • 11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 CSL Limited Recent Developments
• 11.3 Croda
  • 11.3.1 Croda Corporation Information
  • 11.3.2 Croda Overview
  • 11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Croda Recent Developments
• 11.4 SEPPIC
  • 11.4.1 SEPPIC Corporation Information
  • 11.4.2 SEPPIC Overview
  • 11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 SEPPIC Recent Developments
• 11.5 Novavax
  • 11.5.1 Novavax Corporation Information
  • 11.5.2 Novavax Overview
  • 11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Novavax Recent Developments
• 11.6 SPI Pharma
  • 11.6.1 SPI Pharma Corporation Information
  • 11.6.2 SPI Pharma Overview
  • 11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 SPI Pharma Recent Developments
• 11.7 Phibro
  • 11.7.1 Phibro Corporation Information
  • 11.7.2 Phibro Overview
  • 11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Phibro Recent Developments
• 11.8 SDA BIO
  • 11.8.1 SDA BIO Corporation Information
  • 11.8.2 SDA BIO Overview
  • 11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 SDA BIO Recent Developments
• 11.9 Invivogen
  • 11.9.1 Invivogen Corporation Information
  • 11.9.2 Invivogen Overview
  • 11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Invivogen Recent Developments
• 11.10 Tj Kaiwei
  • 11.10.1 Tj Kaiwei Corporation Information
  • 11.10.2 Tj Kaiwei Overview
  • 11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Tj Kaiwei Recent Developments
• 11.11 OZ Biosciences
  • 11.11.1 OZ Biosciences Corporation Information
  • 11.11.2 OZ Biosciences Overview
  • 11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 OZ Biosciences Recent Developments
• 11.12 Brenntag Biosector
  • 11.12.1 Brenntag Biosector Corporation Information
  • 11.12.2 Brenntag Biosector Overview
  • 11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Brenntag Biosector Recent Developments
• 11.13 MVP Laboratories
  • 11.13.1 MVP Laboratories Corporation Information
  • 11.13.2 MVP Laboratories Overview
  • 11.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 MVP Laboratories Recent Developments
• 11.14 Zhuoyue
  • 11.14.1 Zhuoyue Corporation Information
  • 11.14.2 Zhuoyue Overview
  • 11.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Zhuoyue Recent Developments
• 11.15 Aphios
  • 11.15.1 Aphios Corporation Information
  • 11.15.2 Aphios Overview
  • 11.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Aphios Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Vaccine Adjuvants Industry Chain Analysis
• 12.2 Vaccine Adjuvants Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Vaccine Adjuvants Production Mode & Process
• 12.4 Vaccine Adjuvants Sales and Marketing
  • 12.4.1 Vaccine Adjuvants Sales Channels
  • 12.4.2 Vaccine Adjuvants Distributors
• 12.5 Vaccine Adjuvants Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Vaccine Adjuvants Industry Trends
• 13.2 Vaccine Adjuvants Market Drivers
• 13.3 Vaccine Adjuvants Market Challenges
• 13.4 Vaccine Adjuvants Market Restraints

14 Key Findings in The Global Vaccine Adjuvants Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Aluminum Adjuvant
• Table 3. Major Manufacturers of Emulsions Adjuvant
• Table 4. Major Manufacturers of Others
• Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
• Table 8. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
• Table 9. Global Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
• Table 10. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
• Table 11. Global Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
• Table 12. Global Vaccine Adjuvants Revenue Market Share by Region (2017-2022)
• Table 13. Global Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
• Table 14. Global Vaccine Adjuvants Revenue Market Share by Region (2023-2028)
• Table 15. Global Vaccine Adjuvants Sales by Manufacturers (2017-2022) & (MT)
• Table 16. Global Vaccine Adjuvants Sales Share by Manufacturers (2017-2022)
• Table 17. Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 18. Global Vaccine Adjuvants Revenue Share by Manufacturers (2017-2022)
• Table 19. Vaccine Adjuvants Price by Manufacturers (2017-2022) &(USD/Kg)
• Table 20. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 21. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2021)
• Table 22. Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
• Table 23. Manufacturers Vaccine Adjuvants Product Offered
• Table 24. Date of Manufacturers Enter into Vaccine Adjuvants Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 27. Global Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 28. Global Vaccine Adjuvants Sales Share by Type (2017-2022)
• Table 29. Global Vaccine Adjuvants Sales Share by Type (2023-2028)
• Table 30. Global Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 31. Global Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 32. Global Vaccine Adjuvants Revenue Share by Type (2017-2022)
• Table 33. Global Vaccine Adjuvants Revenue Share by Type (2023-2028)
• Table 34. Vaccine Adjuvants Price by Type (2017-2022) & (USD/Kg)
• Table 35. Global Vaccine Adjuvants Price Forecast by Type (2023-2028) & (USD/Kg)
• Table 36. Global Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 37. Global Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 38. Global Vaccine Adjuvants Sales Share by Application (2017-2022)
• Table 39. Global Vaccine Adjuvants Sales Share by Application (2023-2028)
• Table 40. Global Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 41. Global Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 42. Global Vaccine Adjuvants Revenue Share by Application (2017-2022)
• Table 43. Global Vaccine Adjuvants Revenue Share by Application (2023-2028)
• Table 44. Vaccine Adjuvants Price by Application (2017-2022) & (USD/Kg)
• Table 45. Global Vaccine Adjuvants Price Forecast by Application (2023-2028) & (USD/Kg)
• Table 46. North America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 47. North America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 48. North America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 49. North America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 50. North America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 51. North America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 52. North America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 53. North America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 54. North America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
• Table 55. North America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
• Table 56. North America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
• Table 57. North America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
• Table 58. Europe Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 59. Europe Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 60. Europe Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 61. Europe Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 62. Europe Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 63. Europe Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 64. Europe Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 65. Europe Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 66. Europe Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
• Table 67. Europe Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
• Table 68. Europe Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
• Table 69. Europe Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
• Table 70. Asia Pacific Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 71. Asia Pacific Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 72. Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 73. Asia Pacific Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 74. Asia Pacific Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 75. Asia Pacific Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 76. Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 77. Asia Pacific Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 78. Asia Pacific Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
• Table 79. Asia Pacific Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
• Table 80. Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
• Table 81. Asia Pacific Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
• Table 82. Latin America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 83. Latin America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 84. Latin America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 85. Latin America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 86. Latin America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 87. Latin America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 88. Latin America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 89. Latin America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 90. Latin America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
• Table 91. Latin America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
• Table 92. Latin America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
• Table 93. Latin America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
• Table 94. Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
• Table 95. Middle East and Africa Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
• Table 96. Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
• Table 97. Middle East and Africa Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
• Table 98. Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
• Table 99. Middle East and Africa Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
• Table 100. Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
• Table 101. Middle East and Africa Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
• Table 102. Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
• Table 103. Middle East and Africa Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
• Table 104. Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
• Table 105. Middle East and Africa Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
• Table 106. GSK Corporation Information
• Table 107. GSK Description and Major Businesses
• Table 108. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 109. GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 110. GSK Recent Developments
• Table 111. CSL Limited Corporation Information
• Table 112. CSL Limited Description and Major Businesses
• Table 113. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 114. CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 115. CSL Limited Recent Developments
• Table 116. Croda Corporation Information
• Table 117. Croda Description and Major Businesses
• Table 118. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 119. Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 120. Croda Recent Developments
• Table 121. SEPPIC Corporation Information
• Table 122. SEPPIC Description and Major Businesses
• Table 123. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 124. SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 125. SEPPIC Recent Developments
• Table 126. Novavax Corporation Information
• Table 127. Novavax Description and Major Businesses
• Table 128. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 129. Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 130. Novavax Recent Developments
• Table 131. SPI Pharma Corporation Information
• Table 132. SPI Pharma Description and Major Businesses
• Table 133. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 134. SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 135. SPI Pharma Recent Developments
• Table 136. Phibro Corporation Information
• Table 137. Phibro Description and Major Businesses
• Table 138. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 139. Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 140. Phibro Recent Developments
• Table 141. SDA BIO Corporation Information
• Table 142. SDA BIO Description and Major Businesses
• Table 143. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 144. SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 145. SDA BIO Recent Developments
• Table 146. Invivogen Corporation Information
• Table 147. Invivogen Description and Major Businesses
• Table 148. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 149. Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 150. Invivogen Recent Developments
• Table 151. Tj Kaiwei Corporation Information
• Table 152. Tj Kaiwei Description and Major Businesses
• Table 153. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 154. Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 155. Tj Kaiwei Recent Developments
• Table 156. OZ Biosciences Corporation Information
• Table 157. OZ Biosciences Description and Major Businesses
• Table 158. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 159. OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 160. OZ Biosciences Recent Developments
• Table 161. Brenntag Biosector Corporation Information
• Table 162. Brenntag Biosector Description and Major Businesses
• Table 163. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 164. Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 165. Brenntag Biosector Recent Developments
• Table 166. MVP Laboratories Corporation Information
• Table 167. MVP Laboratories Description and Major Businesses
• Table 168. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 169. MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 170. MVP Laboratories Recent Developments
• Table 171. Zhuoyue Corporation Information
• Table 172. Zhuoyue Description and Major Businesses
• Table 173. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 174. Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 175. Zhuoyue Recent Developments
• Table 176. Aphios Corporation Information
• Table 177. Aphios Description and Major Businesses
• Table 178. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 179. Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
• Table 180. Aphios Recent Developments
• Table 181. Key Raw Materials Lists
• Table 182. Raw Materials Key Suppliers Lists
• Table 183. Vaccine Adjuvants Distributors List
• Table 184. Vaccine Adjuvants Customers List
• Table 185. Vaccine Adjuvants Market Trends
• Table 186. Vaccine Adjuvants Market Drivers
• Table 187. Vaccine Adjuvants Market Challenges
• Table 188. Vaccine Adjuvants Market Restraints
• Table 189. Research Programs/Design for This Report
• Table 190. Key Data Information from Secondary Sources
• Table 191. Key Data Information from Primary Sources

List of Figures

• Figure 1. Vaccine Adjuvants Product Picture
• Figure 3. Global Vaccine Adjuvants Market Share by Type in 2021 & 2028
• Figure 3. Aluminum Adjuvant Product Picture
• Figure 4. Emulsions Adjuvant Product Picture
• Figure 5. Others Product Picture
• Figure 6. Global Vaccine Adjuvants Market Share by Application in 2021 & 2028
• Figure 7. Human Vaccine
• Figure 8. Veterinary Vaccine
• Figure 9. Vaccine Adjuvants Report Years Considered
• Figure 10. Global Vaccine Adjuvants Sales 2017-2028 (MT)
• Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
• Figure 13. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
• Figure 15. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
• Figure 16. North America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
• Figure 17. North America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
• Figure 19. Europe Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
• Figure 21. Asia-Pacific Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
• Figure 23. Latin America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
• Figure 25. Middle East & Africa Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Vaccine Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Vaccine Adjuvants in the World: Market Share by Vaccine Adjuvants Revenue in 2021
• Figure 28. Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 30. Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 31. Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 32. Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 33. North America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 34. North America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 35. North America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 36. North America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 37. North America Vaccine Adjuvants Sales Share by Country (2017-2028)
• Figure 38. North America Vaccine Adjuvants Revenue Share by Country (2017-2028)
• Figure 39. U.S. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 42. Europe Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 44. Europe Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Vaccine Adjuvants Sales Share by Country (2017-2028)
• Figure 46. Europe Vaccine Adjuvants Revenue Share by Country (2017-2028)
• Figure 47. Germany Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 48. France Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Vaccine Adjuvants Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Vaccine Adjuvants Revenue Share by Region (2017-2028)
• Figure 58. China Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 61. India Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 63. Taiwan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 67. Philippines Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 69. Latin America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 70. Latin America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Vaccine Adjuvants Sales Share by Country (2017-2028)
• Figure 73. Latin America Vaccine Adjuvants Revenue Share by Country (2017-2028)
• Figure 74. Mexico Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Vaccine Adjuvants Sales Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Vaccine Adjuvants Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Vaccine Adjuvants Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Vaccine Adjuvants Revenue Share by Country (2017-2028)
• Figure 83. Turkey Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 85. U.A.E Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
• Figure 86. Vaccine Adjuvants Value Chain
• Figure 87. Vaccine Adjuvants Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed